Answers are grounded in this paper and cite their sources.
Tramadol had a significantly lower rate of NMU than comparator opioids and was less likely to be diverted or used via higher-risk non-oral routes. These findings support previous evaluations by WHO and the United States Drug Enforcement Agency that concluded that tramadol has a low potential for abuse.
No takes yet. Share an insight, caveat, or question.
Green et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: